Literature DB >> 27073663

Three histologically distinct cancers of the uterine corpus: A case report and review of the literature.

Hisashi Masuyama1, Junko Haraga1, Takashi Nishida1, Chikako Ogawa1, Tomoyuki Kusumoto1, Keiichiro Nakamura1, Noriko Seki1, Hiroyuki Yanai2, Yuji Hiramatsu1.   

Abstract

Collision tumors, which are characterized by the coexistence of two or more completely distinct and independent tumors in the uterine corpus, are very rare. A collision tumor is mainly composed of two distinct tumor types, epithelial and mesenchymal. To the best of our knowledge, there has only been a single case in which a choriocarcinoma with an endometrial carcinoma were coexistent but histologically distinct. We herein report the first case of a collision tumor in a 52-year-old woman, with a history of two pregnancies and two deliveries. The collision tumor was composed of three histologically distinct neoplasms in the uterine corpus, namely an endometrioid carcinoma, an undifferentiated carcinoma and a choriocarcinoma. The patient underwent hysterectomy, bilateral adnexectomy and pelvic lymph node dissection, followed by six cycles of adjuvant chemotherapy with paclitaxel/carboplatin due to the high risk of endometrial cancer, and an additional five cycles of chemotherapy with methotrexate, as the β-human chorionic gonadotropin level was beyond the normal range. Following adjuvant chemotherapy, the tumor markers were within normal limits and no relapses of the cancer have been observed during 1 year of follow-up. Diagnosing a collision tumor prior to surgery is difficult if the neoplasms are in close proximity, or if one of the tumors predominates. Careful pathological examination is crucial for accurately diagnosing the neoplasms in a collision tumor and ensuring appropriate management and a favorable prognosis.

Entities:  

Keywords:  choriocarcinoma; collision tumor; endometrioid adenocarcinoma; undifferentiated carcinoma; uterine corpus

Year:  2016        PMID: 27073663      PMCID: PMC4812600          DOI: 10.3892/mco.2016.770

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  22 in total

1.  Collision of endometrioid carcinoma and stromal sarcoma of the uterus: a report of two cases.

Authors:  K Y Lam; U S Khoo; A Cheung
Journal:  Int J Gynecol Pathol       Date:  1999-01       Impact factor: 2.762

Review 2.  Collision of uterine rhabdoid tumor and endometrioid adenocarcinoma: a case report and review of the literature.

Authors:  E M Gaertner; J H Farley; R R Taylor; S A Silver
Journal:  Int J Gynecol Pathol       Date:  1999-10       Impact factor: 2.762

3.  Pure Choriocarcinoma of the Ovary in Silver-Russell Syndrome.

Authors:  Tomoko Haruma; Chikako Ogawa; Takeshi Nishida; Tomoyuki Kusumoto; Keiichiro Nakamura; Noriko Seki; Takaaki Katayama; Yuji Hiramatsu
Journal:  Acta Med Okayama       Date:  2015       Impact factor: 0.892

4.  Molecular genetic analysis of nongestational choriocarcinoma in a postmenopausal woman: a case report and literature review.

Authors:  Yukihiro Hirata; Nozomu Yanaihara; Satoshi Yanagida; Kenji Fukui; Kimiharu Iwadate; Takako Kiyokawa; Tadao Tanaka
Journal:  Int J Gynecol Pathol       Date:  2012-07       Impact factor: 2.762

5.  Molecular genetic analyses of choriocarcinoma.

Authors:  J Zhao; Y Xiang; X R Wan; F Z Feng; Q C Cui; X Y Yang
Journal:  Placenta       Date:  2009-07-31       Impact factor: 3.481

6.  Gestational and nongestational trophoblastic tumors distinguished by DNA analysis.

Authors:  R A Fisher; E S Newlands; A J Jeffreys; G M Boxer; R H Begent; G J Rustin; K D Bagshawe
Journal:  Cancer       Date:  1992-02-01       Impact factor: 6.860

7.  The impact of molecular genetic diagnosis on the management of women with hCG-producing malignancies.

Authors:  Rosemary A Fisher; Philip M Savage; Caitriona MacDermott; Jane Hook; Neil J Sebire; Iain Lindsay; Michael J Seckl
Journal:  Gynecol Oncol       Date:  2007-10-22       Impact factor: 5.482

8.  Pure nongestational uterine choriocarcinoma in a postmenopausal Chinese woman confirmed with short tandem repeat analysis.

Authors:  Yingmei Wang; Yufang Yang; Fei Teng; Huiying Zhang; Fengxia Xue
Journal:  Am J Obstet Gynecol       Date:  2014-04-13       Impact factor: 8.661

9.  Immunocytochemical study of an endometrial diffuse clear cell stromal sarcoma and other endometrial stromal sarcomas.

Authors:  B Lifschitz-Mercer; B Czernobilsky; R Dgani; G Dallenbach-Hellweg; R Moll; W W Franke
Journal:  Cancer       Date:  1987-04-15       Impact factor: 6.860

10.  Endometrioid adenocarcinoma with choriocarcinomatous differentiation: A case report and review of the literature.

Authors:  Mitsuaki Ishida; Hidetoshi Okabe
Journal:  Oncol Lett       Date:  2013-06-28       Impact factor: 2.967

View more
  1 in total

Review 1.  Dedifferentiated endometrioid adenocarcinoma with trophoblastic components and elevated serum alfa-fetoprotein: A case report and literature review.

Authors:  He Cai; Rong Zhou; Wanying Liang; Jianliu Wang
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.